HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

Abstract
Cerebral ischemia of 5 min duration was induced in unanesthetized Mongolian gerbils by bilateral occlusion of the carotid arteries. The extent of ischemic injury was assessed behaviorally by measuring the increases in locomotor activity following ischemia and by a histopathological assessment of the extent of CA1 hippocampal pyramidal cell injury and loss 5 days after ischemia. The A2a adenosine receptor selective antagonists 8-(3-chlorostyryl) caffeine (CSC; 0.1 mg/kg i.p.) and 4-amino-1-phenyl[1,2,4]-triazolo[4,3-a] quinoxaline (CP 66,713; 0.1 mg/kg i.p.) reduced the extent of ischemia-induced injury. An A1 selective receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 1.0 mg/kg i.p.), enhanced ischemia-evoked injury. These results suggest that adenosine A2a receptor antagonists may be useful for the prevention of cerebral injuries resulting from stroke or cardiac arrest.
AuthorsJ W Phillis
JournalBrain research (Brain Res) Vol. 705 Issue 1-2 Pg. 79-84 (Dec 24 1995) ISSN: 0006-8993 [Print] Netherlands
PMID8821736 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Purinergic P1 Receptor Antagonists
  • Pyrazines
  • Xanthines
  • 8-(3-chlorostyryl)caffeine
  • Caffeine
  • CP 66713
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Dimethyl Sulfoxide
Topics
  • Animals
  • Behavior, Animal (drug effects)
  • Caffeine (analogs & derivatives, pharmacology)
  • Carotid Arteries (physiopathology)
  • Cerebral Cortex (blood supply, chemistry, physiopathology)
  • Cerebrovascular Disorders (drug therapy, physiopathology)
  • Dimethyl Sulfoxide (pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Gerbillinae
  • Locomotion (drug effects)
  • Male
  • Purinergic P1 Receptor Antagonists
  • Pyrazines (pharmacology)
  • Reperfusion Injury (drug therapy)
  • Xanthines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: